#1
PRESCRIBED
MONOCLONAL ANTIBODY TREATMENT FOR NEWLY DIAGNOSED MULTIPLE MYELOMA*
*ACCORDING TO IQVIA CLAIMS DATA
Learn about DARZALEX FASPRO® + VRd, the FDA-approved treatment combination for people with newly diagnosed multiple myeloma who are eligible to receive a stem cell transplant that uses their own stem cells*
Learn about FDA-approved
FDA=U.S. Food and Drug Administation; VRd=bortezomib (V) + lenalidomide (R) + dexamethasone (d).